Foster & Motley Inc Becton Dickinson & CO Transaction History

Foster & Motley Inc

$1.58 Billion
Q3 2024

A detailed history of Foster & Motley Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Foster & Motley Inc holds 8,343 shares of BDX stock, worth $1.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,343

Previous 8,997 7.27%

Holding current value

$1.9 Million

Previous $2.1 Million 4.37%

% of portfolio

0.13%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$221.47 - $242.41 $144,841 - $158,536	-654 Reduced 7.27%	8,343 $2.01 Million
Q2 2024 Aug 02, 2024	SELL	$225.07 - $246.17 $110,734 - $121,115	-492 Reduced 5.18%	8,997 $2.1 Million
Q1 2024 Apr 18, 2024	SELL	$233.45 - $247.73 $163,881 - $173,906	-702 Reduced 6.89%	9,489 $2.35 Million
Q4 2023 Feb 01, 2024	SELL	$232.24 - $267.23 $39,016 - $44,894	-168 Reduced 1.62%	10,191 $2.49 Million
Q3 2023 Oct 24, 2023	SELL	$254.9 - $283.59 $32,372 - $36,015	-127 Reduced 1.21%	10,359 $2.68 Million
Q2 2023 Aug 08, 2023	SELL	$238.39 - $265.32 $43,625 - $48,553	-183 Reduced 1.72%	10,486 $2.77 Million
Q1 2023 May 09, 2023	SELL	$229.71 - $259.35 $11,485 - $12,967	-50 Reduced 0.47%	10,669 $2.64 Million
Q4 2022 Feb 09, 2023	SELL	$218.29 - $256.91 $43,003 - $50,611	-197 Reduced 1.8%	10,719 $2.73 Million
Q3 2022 Nov 04, 2022	SELL	$51.03 - $264.23 $3,112 - $16,118	-61 Reduced 0.56%	10,916 $2.43 Million
Q2 2022 Aug 09, 2022	SELL	$234.74 - $275.42 $53,755 - $63,071	-229 Reduced 2.04%	10,977 $2.71 Million
Q1 2022 Apr 28, 2022	SELL	$243.64 - $270.48 $47,509 - $52,743	-195 Reduced 1.71%	11,206 $2.98 Million
Q4 2021 Jan 25, 2022	SELL	$230.08 - $250.94 $39,573 - $43,161	-172 Reduced 1.49%	11,401 $2.87 Million
Q3 2021 Oct 29, 2021	SELL	$232.72 - $256.47 $118,221 - $130,286	-508 Reduced 4.2%	11,573 $2.85 Million
Q2 2021 Jul 20, 2021	SELL	$232.65 - $254.58 $36,293 - $39,714	-156 Reduced 1.27%	12,081 $2.94 Million
Q1 2021 Apr 26, 2021	SELL	$232.09 - $256.88 $121,847 - $134,862	-525 Reduced 4.11%	12,237 $2.98 Million
Q4 2020 Feb 01, 2021	SELL	$221.92 - $245.94 $45,715 - $50,663	-206 Reduced 1.59%	12,762 $3.19 Million
Q3 2020 Oct 19, 2020	SELL	$215.77 - $276.76 $105,727 - $135,612	-490 Reduced 3.64%	12,968 $3.02 Million
Q2 2020 Jul 20, 2020	SELL	$219.9 - $263.41 $195,930 - $234,698	-891 Reduced 6.21%	13,458 $3.22 Million
Q1 2020 Apr 21, 2020	SELL	$195.69 - $279.01 $137,570 - $196,144	-703 Reduced 4.67%	14,349 $3.3 Million
Q4 2019 Feb 05, 2020	SELL	$236.45 - $266.82 $184,194 - $207,852	-779 Reduced 4.92%	15,052 $4.09 Million
Q3 2019 Oct 24, 2019	SELL	$230.58 - $256.08 $111,139 - $123,430	-482 Reduced 2.95%	15,831 $4.01 Million
Q2 2019 Jul 17, 2019	SELL	$217.4 - $246.08 $283,489 - $320,888	-1,304 Reduced 7.4%	16,313 $4.11 Million
Q1 2019 May 08, 2019	SELL	$206.05 - $248.17 $656,681 - $790,917	-3,187 Reduced 15.32%	17,617 $4.4 Million
Q4 2018 Jan 30, 2019	SELL	$204.73 - $257.93 $712,255 - $897,338	-3,479 Reduced 14.33%	20,804 $4.69 Million
Q3 2018 Oct 31, 2018	SELL	$233.07 - $256.0 $1.82 Million - $2 Million	-7,796 Reduced 24.3%	24,283 $6.34 Million
Q2 2018 Jul 24, 2018	SELL	$208.1 - $233.85 $264,287 - $296,989	-1,270 Reduced 3.81%	32,079 $7.69 Million
Q1 2018 May 14, 2018	SELL	$205.46 - $240.27 $183,681 - $214,801	-894 Reduced 2.61%	33,349 $7.23 Million
Q4 2017 Jan 22, 2018	SELL	$189.0 - $222.64 $505,386 - $595,339	-2,674 Reduced 7.24%	34,243 $7.33 Million
Q3 2017 Oct 19, 2017	BUY	$186.89 - $198.9 $6.9 Million - $7.34 Million	36,917	36,917 $7.23 Million

Others Institutions Holding BDX

# of Institutions

1,734

Shares Held

251M

Call Options Held

578K

Put Options Held

765K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.8B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Account

Foster & Motley Inc Becton Dickinson & CO Transaction History